Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Clinical Research (Excluding Clinical Trials)

Abstract 670: Specific ROS generation and monitoring in cancer using radioactive gold nanoparticle

Jihye Choi, Yoon Woo Koh, Hyung Kwon Byeon, Guillem Pratx and Jaemoon Yang
Jihye Choi
1Yonsei University College of Medicine, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoon Woo Koh
1Yonsei University College of Medicine, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyung Kwon Byeon
1Yonsei University College of Medicine, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillem Pratx
2Stanford University School of Medicine, Palo Alto, CA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaemoon Yang
1Yonsei University College of Medicine, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2018-670 Published July 2018
  • Article
  • Info & Metrics
Loading
Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL

Abstract

Radiotherapy is a key treatment and is beneficial in the treatment of about 50% of all cancer patients. Such treatment relies on the deposition of energy (the dose) in tumour cells, typically by irradiation with either high-energy gamma rays or X-rays (photons), or energetic beams of ions, sufficient to damage the cancer cells or their vasculature and thus induce tumour death or nutrient starvation. However, like chemotherapy, photon radiotherapy is non-specific, since a significant dose can be delivered to healthy tissue along the track of the photons, in front and behind the tumour. Therefore, recently several research groups have proposed the use of specifically targeted noble-metal nanoparticles irradiated by radiation as an effective therapeutic tool for treating various malignancies with minimum collateral damage to healthy tissue. In general, the photoelectric absorption cross sections of radiosensitive materials directly depend on atom radius, and thus their radiotherapy effects also depend on atom radius. This physical principle determines that gold (atomic-number Z=79) has a stronger radiation enhancement effect by photoelectric effect. Loading with gold nanoparticles (AuNPs) is one of the promising candidates in this area. Gold NPs have a larger atomic radius than gold atom (~0.17 nm), and thus should have a stronger radiation enhancement effect than gold atom. During irradiation, this results in an enhancement of the energy deposition in the vicinity of the gold particles generate the ROS on the surface due to the generation of photoelectrons, Auger electrons, and characteristic X-rays. ROS play important roles in various cellular process. In particularly, at sufficiently high concentrations, ROS could become an effect that is utilized for various therapeutic application such as apoptosis. Herein, we synthesized the radiosensitizer PEGylated gold nanoparticles (RPAuNPs) for generation and measuring of ROS on surface by radiation exposure. First, gold nanoparticles (AuNPs) was prepared by one-pot synthesis and the sharpness and size were efficiently controlled by adjusting the amount of reducing agent. Furthermore, they were replaced with heterobifunctional PEG (COOH-PEG-SH) not only to serve as a biocompatible stabilizer (PAuNPs) and but also to conjugate Dihydrorhodamine 123 (DHR 123) (RPAuNPs) as ROS sensor. Well-engineered formation of RPAuNPs was verified by transmission electron microscopy (TEM) showing their overall size of 50 nm. In addition, UV-Vis data strongly demonstrated successful synthesis. We evaluated their functional use in inducing ROS and the results showed that our radiosensitizing agents exhibited the feasibility of effective ROS generation under x-ray radiation. And we investigated there in vitro/in vivo imaging and therapeutic efficacies, optical properties, biocompatibility for tumor cell.

Citation Format: Jihye Choi, Yoon Woo Koh, Hyung Kwon Byeon, Guillem Pratx, Jaemoon Yang. Specific ROS generation and monitoring in cancer using radioactive gold nanoparticle [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 670.

  • ©2018 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 78 (13 Supplement)
July 2018
Volume 78, Issue 13 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 670: Specific ROS generation and monitoring in cancer using radioactive gold nanoparticle
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract 670: Specific ROS generation and monitoring in cancer using radioactive gold nanoparticle
Jihye Choi, Yoon Woo Koh, Hyung Kwon Byeon, Guillem Pratx and Jaemoon Yang
Cancer Res July 1 2018 (78) (13 Supplement) 670; DOI: 10.1158/1538-7445.AM2018-670

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 670: Specific ROS generation and monitoring in cancer using radioactive gold nanoparticle
Jihye Choi, Yoon Woo Koh, Hyung Kwon Byeon, Guillem Pratx and Jaemoon Yang
Cancer Res July 1 2018 (78) (13 Supplement) 670; DOI: 10.1158/1538-7445.AM2018-670
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Clinical Research (Excluding Clinical Trials)

  • Abstract 6498: Preoperative treatment remodels immune microenvironment via decreasing pro-tumorigenic and increasing anti-tumorigenic immune cells in the locally advanced gastric cancer
  • Abstract PL01-01: Personal regulome navigation of cancer
  • Abstract 6512: Tissue engineered metastases to improve cancer immunotherapy
Show more Clinical Research (Excluding Clinical Trials)

Poster Presentations - Proffered Abstracts

  • Abstract 6498: Preoperative treatment remodels immune microenvironment via decreasing pro-tumorigenic and increasing anti-tumorigenic immune cells in the locally advanced gastric cancer
  • Abstract PL01-01: Personal regulome navigation of cancer
  • Abstract 6512: Tissue engineered metastases to improve cancer immunotherapy
Show more Poster Presentations - Proffered Abstracts

Poster Presentations - Radiation Oncology

  • Abstract 668: Electron paramagnetic resonance (EPR) pO2 image-guided tumor biopsies to analyze hypoxia-induced proteins
  • Abstract 673: Preoperative radiation therapy in advanced carcinoma colon with post-colostomy intestinal obstruction: The first report
Show more Poster Presentations - Radiation Oncology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement